Compounds > aripiprazole

Page last updated: 2024-08-24

aripiprazole and dextroamphetamine

aripiprazole has been researched along with dextroamphetamine in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	6 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Glaser, PE; Lile, JA; Rush, CR; Stoops, WW	1
Stoops, WW	1
Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W	1
Evenden, J; Jonak, G; Ross, L; Zhou, J	1
Mavrikaki, M; Nomikos, GG; Panagis, G	1
Glaser, PE; Hays, LR; Lile, JA; Rush, CR; Stoops, WW	1
Bäckström, P; Etelälahti, TJ; Hyytiä, P	1
Charntikov, S; Crawford, CA; Der-Ghazarian, T; Lee, RJ; McDougall, SA; Varela, FA	1
Bojarski, AJ; Bucki, A; Byrtus, H; Czopek, A; Kalinowska-Tłuścik, J; Kazek, G; Kołaczkowski, M; Partyka, A; Pawłowski, M; Piaskowska, A; Wesołowska, A	1

Reviews

2 review(s) available for aripiprazole and dextroamphetamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Pharmacotherapy of methamphetamine addiction: an update. Substance abuse, 2008, Volume: 29, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders	2008

Other Studies

8 other study(ies) available for aripiprazole and dextroamphetamine

Article	Year
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug and alcohol dependence, 2006, Sep-15, Volume: 84, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Pressure; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Piperazines; Quinolones; Substance-Related Disorders; Surveys and Questionnaires	2006
Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine. Experimental and clinical psychopharmacology, 2006, Volume: 14, Issue:4 Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Area Under Curve; Aripiprazole; Central Nervous System Stimulants; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Humans; Piperazines; Psychomotor Performance; Quinolones	2006
A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs. Behavioural pharmacology, 2009, Volume: 20, Issue:3 Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Benzodiazepines; Chlordiazepoxide; Conditioning, Operant; Conflict, Psychological; Dextroamphetamine; Diazepam; Electroshock; Flumazenil; Male; Piperazines; Punishment; Pyridazines; Quinolones; Rats; Rats, Sprague-Dawley; Triazoles; Yohimbine	2009
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania. The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:4 Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Locomotion; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Self Stimulation	2010
Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:11 Topics: Adult; Antipsychotic Agents; Aripiprazole; Behavior; Blood Pressure; Cardiovascular System; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Discrimination Learning; Female; Heart Rate; Humans; Male; Middle Aged; Piperazines; Quinolones; Substance-Related Disorders; Surveys and Questionnaires	2011
Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole. Addiction biology, 2011, Volume: 16, Issue:1 Topics: Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Male; Motivation; Motor Activity; Piperazines; Psychomotor Performance; Quinolones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Reinforcement, Psychology; Self Administration; Sucrose	2011
Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:4 Topics: Age Factors; Animals; Antipsychotic Agents; Aripiprazole; Binding Sites; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Time Factors; Up-Regulation	2014
Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent. Bioorganic & medicinal chemistry, 2015, Jul-01, Volume: 23, Issue:13 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Depression; Dextroamphetamine; Hydantoins; Hyperkinesis; Imidazolidines; Male; Mice; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming	2015